INmune Bio, Inc. (INMB) Tops Q2 EPS by 14c
INmune Bio, Inc. (NASDAQ: INMB) reported Q2 EPS of ($0.05), $0.14 better than the analyst estimate of ($0.19).
For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.
INmune Bio, Inc. (NASDAQ: INMB) reported Q2 EPS of ($0.05), $0.14 better than the analyst estimate of ($0.19).
For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.